secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76231 grounded facts newest August 28, 2026, 4:49 PM ET RSS · JSON

Showing 351–400 of 76231

Departed

Grant C. Bogle

Director
NUVL · Nuvalent, Inc.
Effective
2026-07-15
Filed
July 15, 2026, 9:03 AM ET
each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company’s board of directors
Departed

James R. Porter, Ph.D.

Director
NUVL · Nuvalent, Inc.
Effective
2026-07-15
Filed
July 15, 2026, 9:03 AM ET
each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company’s board of directors
Departed

Sapna Srivastava, Ph.D.

Director
NUVL · Nuvalent, Inc.
Effective
2026-07-15
Filed
July 15, 2026, 9:03 AM ET
each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company’s board of directors
Departed

Ron Squarer

Director
NUVL · Nuvalent, Inc.
Effective
2026-07-15
Filed
July 15, 2026, 9:03 AM ET
each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company’s board of directors
Departed

Cameron A. Wheeler, Ph.D.

Director
NUVL · Nuvalent, Inc.
Effective
2026-07-15
Filed
July 15, 2026, 9:03 AM ET
each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company’s board of directors
Departed

Michael L. Meyers, M.D., Ph.D.

Director
NUVL · Nuvalent, Inc.
Effective
2026-07-15
Filed
July 15, 2026, 9:03 AM ET
each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company’s board of directors
Departed

David Weinstein

member of the board of directors
NLCP · NewLake Capital Partners, Inc.
Effective
2026-07-31
Filed
July 15, 2026, 9:00 AM ET
On July 14, 2026 , David Weinstein notified NewLake Capital Partners, Inc. (the "Company") of his resignation from his position as a member of the board of directors (the "Board") of the Company, effective July 31, 2026 the ("Effective Date").
Departed

Kristian M. Gathright

Trustee
WSR · Whitestone REIT
Effective
2026-07-14
Filed
July 14, 2026, 4:53 PM ET
Pursuant to the terms of the Merger Agreement, as of the Company Merger Effective Time, Amy S. Feng, Julia B. Buthman, Kristian M. Gathright, David K. Holeman, Jeffrey A. Jones, and Donald A. Miller ceased serving as members of the Company’s board of trustees and each committee thereof.
Departed

Amy S. Feng

Trustee
WSR · Whitestone REIT
Effective
2026-07-14
Filed
July 14, 2026, 4:53 PM ET
Pursuant to the terms of the Merger Agreement, as of the Company Merger Effective Time, Amy S. Feng, Julia B. Buthman, Kristian M. Gathright, David K. Holeman, Jeffrey A. Jones, and Donald A. Miller ceased serving as members of the Company’s board of trustees and each committee thereof.
Departed

Julia B. Buthman

Trustee
WSR · Whitestone REIT
Effective
2026-07-14
Filed
July 14, 2026, 4:53 PM ET
Pursuant to the terms of the Merger Agreement, as of the Company Merger Effective Time, Amy S. Feng, Julia B. Buthman, Kristian M. Gathright, David K. Holeman, Jeffrey A. Jones, and Donald A. Miller ceased serving as members of the Company’s board of trustees and each committee thereof.
Departed

David K. Holeman

Trustee
WSR · Whitestone REIT
Effective
2026-07-14
Filed
July 14, 2026, 4:53 PM ET
Pursuant to the terms of the Merger Agreement, as of the Company Merger Effective Time, Amy S. Feng, Julia B. Buthman, Kristian M. Gathright, David K. Holeman, Jeffrey A. Jones, and Donald A. Miller ceased serving as members of the Company’s board of trustees and each committee thereof.
Departed

Jeffrey A. Jones

Trustee
WSR · Whitestone REIT
Effective
2026-07-14
Filed
July 14, 2026, 4:53 PM ET
Pursuant to the terms of the Merger Agreement, as of the Company Merger Effective Time, Amy S. Feng, Julia B. Buthman, Kristian M. Gathright, David K. Holeman, Jeffrey A. Jones, and Donald A. Miller ceased serving as members of the Company’s board of trustees and each committee thereof.
Departed

Donald A. Miller

Trustee
WSR · Whitestone REIT
Effective
2026-07-14
Filed
July 14, 2026, 4:53 PM ET
Pursuant to the terms of the Merger Agreement, as of the Company Merger Effective Time, Amy S. Feng, Julia B. Buthman, Kristian M. Gathright, David K. Holeman, Jeffrey A. Jones, and Donald A. Miller ceased serving as members of the Company’s board of trustees and each committee thereof.
Departed

Oliver G. Richard, III

Director
CQP · Cheniere Energy Partners, L.P.
Effective
2026-07-14
Filed
July 14, 2026, 4:28 PM ET
James R. Ball and Oliver G. Richard, III each resigned as a member of the Board.
Departed

James R. Ball

Director
CQP · Cheniere Energy Partners, L.P.
Effective
2026-07-14
Filed
July 14, 2026, 4:28 PM ET
James R. Ball and Oliver G. Richard, III each resigned as a member of the Board.
Departed

Robert A. Parks

Chief Accounting Officer
FTRE · Fortrea Holdings Inc.
Effective
2026-08-07
Successor
Carrie Russell
Filed
July 14, 2026, 4:05 PM ET
On July 8, 2026, Robert A. Parks informed Fortrea Holdings Inc. (the “Company”) of his intention to resign from his position as Chief Accounting Officer and principal accounting officer to pursue an opportunity outside the contract research organization industry.
Departed

Frank Nitkiewicz

Executive Vice President, Chief Operating Officer and Chief Financial Officer
Federal Home Loan Bank of Boston
Filed
July 14, 2026, 1:52 PM ET
On July 8, 2026, Frank Nitkiewicz, the Executive Vice President, Chief Operating Officer and Chief Financial Officer of the Federal Home Loan Bank of Boston (the “Bank”), notified the Bank of his intent to retire by March 31, 2027.
Departed

Evan Cutler

Chief Financial Officer
GPB Automotive Portfolio, LP
Effective
2026-06-30
Filed
July 14, 2026, 10:49 AM ET
On June 30, 2026, as part of and in accordance with the wind-down process, Mr. Cutler’s employment with Highline ended, and he ceased serving as the Partnership’s principal financial and accounting officer.
Departed

Owen Hughes

Director
XOMA · XOMA Royalty Corp
Effective
2026-07-14
Filed
July 14, 2026, 9:10 AM ET
each of Jack L. Wyszomierski, Heather L. Franklin, Natasha Hernday, Owen Hughes, Barbara Kosacz, Joseph M. Limber and Matthew Perry, voluntarily resigned as directors of the Company
Departed

Matthew Perry

Director
XOMA · XOMA Royalty Corp
Effective
2026-07-14
Filed
July 14, 2026, 9:10 AM ET
each of Jack L. Wyszomierski, Heather L. Franklin, Natasha Hernday, Owen Hughes, Barbara Kosacz, Joseph M. Limber and Matthew Perry, voluntarily resigned as directors of the Company
Departed

Natasha Hernday

Director
XOMA · XOMA Royalty Corp
Effective
2026-07-14
Filed
July 14, 2026, 9:10 AM ET
each of Jack L. Wyszomierski, Heather L. Franklin, Natasha Hernday, Owen Hughes, Barbara Kosacz, Joseph M. Limber and Matthew Perry, voluntarily resigned as directors of the Company
Departed

Jack L. Wyszomierski

Director
XOMA · XOMA Royalty Corp
Effective
2026-07-14
Filed
July 14, 2026, 9:10 AM ET
each of Jack L. Wyszomierski, Heather L. Franklin, Natasha Hernday, Owen Hughes, Barbara Kosacz, Joseph M. Limber and Matthew Perry, voluntarily resigned as directors of the Company
Departed

Barbara Kosacz

Director
XOMA · XOMA Royalty Corp
Effective
2026-07-14
Filed
July 14, 2026, 9:10 AM ET
each of Jack L. Wyszomierski, Heather L. Franklin, Natasha Hernday, Owen Hughes, Barbara Kosacz, Joseph M. Limber and Matthew Perry, voluntarily resigned as directors of the Company
Departed

Joseph M. Limber

Director
XOMA · XOMA Royalty Corp
Effective
2026-07-14
Filed
July 14, 2026, 9:10 AM ET
each of Jack L. Wyszomierski, Heather L. Franklin, Natasha Hernday, Owen Hughes, Barbara Kosacz, Joseph M. Limber and Matthew Perry, voluntarily resigned as directors of the Company
Departed

Heather L. Franklin

Director
XOMA · XOMA Royalty Corp
Effective
2026-07-14
Filed
July 14, 2026, 9:10 AM ET
each of Jack L. Wyszomierski, Heather L. Franklin, Natasha Hernday, Owen Hughes, Barbara Kosacz, Joseph M. Limber and Matthew Perry, voluntarily resigned as directors of the Company
Departed

Stephen Mackintosh

Chief Investment Officer
SUIG · SUI Group Holdings Ltd.
Effective
2026-07-08
Filed
July 14, 2026, 9:06 AM ET
On July 8, 2026, Stephen Mackintosh notified Sui Group Holdings Limited (the “Company”) of his resignation from his position as Chief Investment Officer of the Company, effective July 8, 2026.
Departed

Paul J. Hennessy

Chief Executive Officer
SSTK · Shutterstock, Inc.
Effective
2026-07-12
Successor
Rik Powell
Filed
July 13, 2026, 5:09 PM ET
On July 12, 2026, Paul J. Hennessy notified the Board of Directors (the “Board”) of Shutterstock, Inc. (the “Company”) of his decision to step down as the Company’s Chief Executive Officer and as a member of the Board, effective immediately.
Departed

Robert M. Ginnan

Chief Financial Officer
WKHS · Workhorse Group Inc.
Effective
2026-07-13
Successor
Jody Davis
Filed
July 13, 2026, 5:01 PM ET
on July 13, 2026, Robert M. Ginnan and the Company agreed that Mr. Ginnan will no longer serve as the Company’s Chief Financial Officer, effective July 13, 2026.
Departed

Edward M. Weil, Jr.

Chairman of the Board
NYC · American Strategic Investment Co.
Effective
2026-07-09
Successor
Nicholas S. Schorsch, Jr.
Filed
July 13, 2026, 4:58 PM ET
On July 9, 2026, Edward M. Weil, Jr., a Class III director and Chairman of the Board of Directors (the “ Board ”) of American Strategic Investment Co. (the “ Company ”), notified the Company of his resignation as a director on the Board, effective immediately.
Departed

Kent P. Hawryluk

Chief Executive Officer
MBX · MBX Biosciences, Inc.
Effective
2026-07-13
Successor
Steven Hoerter
Filed
July 13, 2026, 4:46 PM ET
Departure of Chief Executive Officer Kent P. Hawryluk will be stepping away from his role as the Company’s Chief Executive Officer and end his services as a member of the Board effective as of July 13, 2026.
Departed

Lawson Whiting

President and Chief Executive Officer
BF-A · BROWN FORMAN CORP
Filed
July 13, 2026, 4:40 PM ET
On July 13, 2026, Lawson Whiting announced his decision to retire as President and Chief Executive Officer of Brown-Forman Corporation (the “Company”) after nearly 30 years of distinguished service to the Company, effective upon the appointment of his successor.
Departed

Douglas Beck

Principal Accounting Officer and Senior Vice President of Finance, Controller
SHFS · SHF Holdings, Inc.
Effective
2026-07-31
Filed
July 13, 2026, 4:27 PM ET
On July 7, 2026, Douglas Beck, the Principal Accounting Officer and Senior Vice President of Finance, Controller of SHF Holdings, Inc. (the “Company”), informed the Company of his decision to resign from his roles at the Company effective July 31, 2026.
Departed

Aziz Mottiwala

Chief Commercial Officer
TARS · Tarsus Pharmaceuticals, Inc.
Effective
2026-07-15
Filed
July 13, 2026, 4:11 PM ET
On July 13, 2026, Tarsus Pharmaceuticals, Inc. (the “Company”) announced that Aziz Mottiwala would be leaving his role as the Company’s Chief Commercial Officer and leaving his employment with the Company on July 15, 2026, to pursue a new opportunity as Chief Executive Officer of a public medical device company.
Departed

Michael Boukaya

Executive Vice President and Chief Operating Officer
CEVA · CEVA INC
Effective
2026-08-01
Filed
July 13, 2026, 4:06 PM ET
On July 8, 2026, Ceva, Inc. (the “Company”) and Michael Boukaya, Executive Vice President and Chief Operating Officer of the Company, mutually agreed that Mr. Boukaya would resign from his position with the Company.
Departed

Miles Everson

director
FRMI · Fermi Inc.
Effective
2026-07-10
Filed
July 13, 2026, 9:15 AM ET
On July 10, 2026, the Board of Directors (the “Board”) of Fermi Inc. (the “Company”) received a letter from Mr. Miles Everson, a director designee of Toby Neugebauer, pursuant to which Mr. Everson resigned as a director of the Company, effective immediately (the “Resignation Letter”).
Departed

Andrew J. Ritter

Director
NORD · Nordicus Partners Corp
Effective
2026-07-07
Filed
July 13, 2026, 9:11 AM ET
On July 7, 2026, Andrew J. Ritter resigned from the Board of Directors of Nordicus Partners Corporation (the “Company”), effective immediately, to pursue other time-consuming business opportunities.
Departed

Robert E. Hoffman

director
ESPR · Esperion Therapeutics, Inc.
Effective
2026-07-13
Filed
July 13, 2026, 9:10 AM ET
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Departed

Sheldon L. Koenig

director
ESPR · Esperion Therapeutics, Inc.
Effective
2026-07-13
Filed
July 13, 2026, 9:10 AM ET
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Departed

Seth H.Z. Fischer

director
ESPR · Esperion Therapeutics, Inc.
Effective
2026-07-13
Filed
July 13, 2026, 9:10 AM ET
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Departed

Jay P. Shepard

director
ESPR · Esperion Therapeutics, Inc.
Effective
2026-07-13
Filed
July 13, 2026, 9:10 AM ET
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Departed

J. Martin Carroll

director
ESPR · Esperion Therapeutics, Inc.
Effective
2026-07-13
Filed
July 13, 2026, 9:10 AM ET
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Departed

Craig Thompson

director
ESPR · Esperion Therapeutics, Inc.
Effective
2026-07-13
Filed
July 13, 2026, 9:10 AM ET
Effective upon the consummation of the Merger, in accordance with the Merger Agreement, each of J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard and Seth H.Z. Fischer, who constituted the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company, and Justin Bateman and Ankit Pareek, the directors of MergerCo immediately prior to the Effective Time, were elected as directors of the Company.
Departed

James W. Roquemore

Director
SSB · SouthState Bank Corp
Effective
2026-07-09
Filed
July 13, 2026, 8:58 AM ET
With deep sadness, SouthState Bank Corporation (the “Company”), announced that James W. Roquemore, a member of the Company’s Board of Directors, passed away on July 9, 2026, after a long illness.
Departed

Robert Jackson

Director
KSEZ · Kinetic Seas Inc.
Effective
2026-07-08
Filed
July 10, 2026, 5:05 PM ET
On July 8, 2026, Robert Jackson, Director of Kinetic Seas Incorporated, notified the Board of Directors of his resignation from all positions with the Company, effective the same day.
Departed

Dr. John R. Anderson

Executive Vice President and Chief Medical Officer
CON · Concentra Group Holdings Parent, Inc.
Effective
2026-12-31
Filed
July 10, 2026, 4:53 PM ET
Dr. John R. Anderson notified Concentra Group Holdings Parent, Inc. (the “Company”) of his retirement from his position as Executive Vice President and Chief Medical Officer of the Company effective as of December 31, 2026.
Departed

Kathy Fish

Director
ORGN · Origin Materials, Inc.
Effective
2026-07-31
Filed
July 10, 2026, 4:38 PM ET
John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou informed the Company on July 9, 2026 that they will step down from the Board of the Company, effective July 31, 2026.
Departed

John Hickox

Director
ORGN · Origin Materials, Inc.
Effective
2026-07-31
Filed
July 10, 2026, 4:38 PM ET
John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou informed the Company on July 9, 2026 that they will step down from the Board of the Company, effective July 31, 2026.
Departed

Jim Stephanou

Director
ORGN · Origin Materials, Inc.
Effective
2026-07-31
Filed
July 10, 2026, 4:38 PM ET
John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou informed the Company on July 9, 2026 that they will step down from the Board of the Company, effective July 31, 2026.
Departed

John Bissell

Director
ORGN · Origin Materials, Inc.
Effective
2026-07-31
Filed
July 10, 2026, 4:38 PM ET
John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou informed the Company on July 9, 2026 that they will step down from the Board of the Company, effective July 31, 2026.
Departed

Craig Rogerson

Director
ORGN · Origin Materials, Inc.
Effective
2026-07-31
Filed
July 10, 2026, 4:38 PM ET
John Bissell, Kathy Fish, John Hickox, Craig Rogerson, and Jim Stephanou informed the Company on July 9, 2026 that they will step down from the Board of the Company, effective July 31, 2026.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.